Effective antigen-specific immunotherapy in the marmoset model of multiple sclerosis

被引:16
作者
McFarland, HI
Lobito, AA
Johnson, MM
Palardy, GR
Yee, CSK
Jordan, EK
Frank, JA
Tresser, N
Genain, CP
Mueller, JP
Matis, LA
Lenardo, MJ
机构
[1] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA
[2] NINDS, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA
[3] NINDS, Lab Diagnost Radiol Res, NIH, Bethesda, MD 20892 USA
[4] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA
[5] Alexion Pharmaceut Inc, New Haven, CT 06511 USA
关键词
D O I
10.4049/jimmunol.166.3.2116
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mature T cells initially respond to Ag by activation and expansion, but high and repeated doses of Ag cause programmed cell death and can suppress T cell-mediated diseases in rodents, We evaluated repeated systemic Ag administration In a marmoset model of experimental allergic encephalomyelitis that closely resembles the human disease multiple sclerosis, We found that treatment with MP4, a chimeric, recombinant polypeptide containing human myelin basic protein and human proteolipid protein epitopes, prevented clinical symptoms and did not exacerbate disease, CNS lesions were also reduced as assessed in vivo by magnetic resonance imaging, Thus, specific Ag-directed therapy can be effective and nontoxic in primates.
引用
收藏
页码:2116 / 2121
页数:6
相关论文
共 43 条
  • [1] AMOR S, 1994, J IMMUNOL, V153, P4349
  • [2] FREQUENCY OF T-CELLS SPECIFIC FOR MYELIN BASIC-PROTEIN AND MYELIN PROTEOLIPID PROTEIN IN BLOOD AND CEREBROSPINAL-FLUID IN MULTIPLE-SCLEROSIS
    CHOU, YK
    BOURDETTE, DN
    OFFNER, H
    WHITHAM, R
    WANG, RY
    HASHIM, GA
    VANDENBARK, AA
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1992, 38 (1-2) : 105 - 113
  • [3] T-CELL DELETION IN HIGH ANTIGEN DOSE THERAPY OF AUTOIMMUNE ENCEPHALOMYELITIS
    CRITCHFIELD, JM
    RACKE, MK
    ZUNIGAPFLUCKER, JC
    CANNELLA, B
    RAINE, CS
    GOVERMAN, J
    LENARDO, MJ
    [J]. SCIENCE, 1994, 263 (5150) : 1139 - 1143
  • [4] EBERS G, 1998, MULT SCLER, P403
  • [5] Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein
    Elliott, EA
    McFarland, HI
    Nye, SH
    Cofiell, R
    Wilson, TM
    Wilkins, JA
    Squinto, SP
    Matis, LA
    Mueller, JP
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (07) : 1602 - 1612
  • [6] Immune tolerance mediated by recombinant proteolipid protein prevents experimental autoimmune encephalomyelitis
    Elliott, EA
    Cofiell, R
    Wilkins, JA
    Raine, CS
    Matis, LA
    Mueller, JP
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1997, 79 (01) : 1 - 11
  • [7] SUPPRESSION OF IMMUNE-RESPONSE - REVERSAL OF DISEASE STATE WITH ANTIGEN IN ALLERGIC ENCEPHALOMYELITIS
    EYLAR, EH
    ROTHENBERG, B
    JACKSON, J
    BROSTOFF, SW
    [J]. NATURE, 1972, 236 (5341) : 74 - +
  • [8] CHRONIC EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN MONKEYS
    FERRARO, A
    CAZZULLO, CL
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1948, 7 (03) : 235 - 260
  • [9] Creation of a model for multiple sclerosis in Callithrix jacchus marmosets
    Genain, CP
    Hauser, SL
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 1997, 75 (03): : 187 - 197
  • [10] Late complications of immune deviation therapy in a nonhuman primate
    Genain, CP
    Abel, K
    Belmar, N
    Villinger, F
    Rosenberg, DP
    Linington, C
    Raine, CS
    Hauser, SL
    [J]. SCIENCE, 1996, 274 (5295) : 2054 - 2057